News Update on Skin Disease : July – 20

Science Press Release Distribution Services

News Update on Skin Disease : July – 20

July 15, 2020 Medical Science 0

Skin disease and handicap: An analysis of the impact of skin conditions

This research sought to quantify the handicapping effect of skin conditions in a far more rigorous way than had previously been attempted. One hundred people who had attended a hospital outpatient clinic during a specified period for treatment of their acne, psoriasis or eczema were interviewed in their homes. A comprehensive and structured interview schedule was used and interviewees were encouraged to talk at length about the impact that their skin conditions had had on their lives. [1]

PSORIATIC ARTHRITIS: OUTCOME OF DISEASE SUBSETS AND RELATIONSHIP OF JOINT DISEASE TO NAIL AND SKIN DISEASE

Subgroups of PsA have been described but their relationship to the mode of onset of arthritis, to DIP joint disease and to nail and skin disease remains controversial. Therefore, the pattern of disease was documented in 100 patients with PsA in whom the mode of onset was known. The patients were divided into six subgroups: monoarthritis; DIP joint disease only; oligoarthntis; polyarthritis; spondyloarthropathy and arthritis mutilans. [2]

Skindex, a Quality-of-Life Measure for Patients with Skin Disease: Reliability, Validity, and Responsiveness

To measure the effects of skin disease on patients’ quality of life, we developed a 61-item self-administered survey instrument called Skindex. Skindex has eight scales, each of which addresses a construct, or an abstract component, in a comprehensive conceptual framework: cognitive effects, social effects, depression, fear, embarrassment, anger, physical discomfort, and physical limitations. Item responses are standardized from 0 (no effect) to 100 (maximal effect); a scale score is the average of responses to items addressing a construct. [3]

Drug Utilization and Cost Analysis for Common Skin Diseases in Dermatology OPD of an Indian Tertiary Care Hospital – A Prescription Survey

Introduction: Epidemiology of skin diseases has been studied and evaluated occasionally. In view of high incidence of skin diseases and economic burden that it poses, there is a need to evaluate the present epidemiology and prescribing pattern of skin disorders.

Objective: To assess common skin conditions, drug utilization patterns and cost analysis in Dermatology Out patients Department (OPD) of Tertiary Care hospital.

Methodology: After taking Ethics committee’s permission, prescriptions of 600 patients attending Dermatology OPD were audited. The prescriptions were analyzed for common skin conditions drug utilization and cost analysis.

Results: The common skin conditions found were Pyoderma and Scabies while common classes of drugs prescribed were antiallergics, antifungals and steroids. Drugs prescribed by Generic name were 16.6% and Brand names were 83.4%. It was revealed that 30% of total drugs dispensed from hospital pharmacy and 70% from outside pharmacy. Average hospital and outside pharmacy costs were INR19.40 and INR116.20, respectively. The outside pharmacy cost of prescription (Spearman’s Rho = -0.130, p < 0.01) as well as cost paid by the patients (Spearman’s Rho = 0.408, p < 0.001) had a negative correlation with the socioeconomic score as the drugs were prescribed irrespective of the socioeconomic class. [4]

Experiences and Perceptions of People with Chronic Skin Disease: A Qualitative Study

Aims: Skin diseases are a common reason for consulting the general practitioner (GP). Few studies have been conducted that explore the topic of chronic skin disease from the patient’s perspective. The aim of this paper was to investigate experiences and perceptions of people with chronic skin diseases and their respective pathways into the health care system.

Study Design: Qualitative study

Place and Duration of Study: GP practices and patients’ homes; between July 2011 and August 2012.

Methodology: Interviews (20-30min) with 16 patients using a semi-structured guideline were conducted. Patients were identified by their respective GP. Adult patients suffering from a chronic skin disease were included. Interviews were taped and transcribed verbatim. Qualitative analysis was conducted by two independent raters. [5]

Reference

[1] Jowett, S. and Ryan, T., 1985. Skin disease and handicap: an analysis of the impact of skin conditions. Social science & medicine, 20(4), pp.425-429.

[2] Jones, S.M., Armas, J.B., Cohen, M.G., Lovell, C.R., Evison, G. and McHugh, N.J., 1994. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Rheumatology, 33(9), pp.834-839.

[3] Chren, M.M., Lasek, R.J., Quinn, L.M., Mostow, E.N. and Zyzanski, S.J., 1996. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. Journal of investigative Dermatology, 107(5), pp.707-713.

[4] Narwane, S.P., Patel, T.C., Shetty, Y.C. and Chikhalkar, S.B., 2011. Drug utilization and cost analysis for common skin diseases in dermatology OPD of an Indian tertiary care hospital-A prescription survey. Journal of Pharmaceutical Research International, pp.9-18.

[5] Esch, M., Rübsam, M.L., Baum, E. and Bösner, S., 2015. Experiences and perceptions of people with chronic skin disease: a qualitative study. Journal of Advances in Medicine and Medical Research, pp.106-113.

 

Leave a Reply

Your email address will not be published. Required fields are marked *